Evidence map›Paper›PMID 38849857›Full record

ReviewDiagnostic pathology2024

POEMS syndrome with undetectable M-protein: a case report and literature review.

Han-Yue Xue, Lin Zhou, Qin-Zhao Yuan, Yang Zhang, Yi-Qun Hao, Shao-Wei Chen, Hong-Kun Wang, Fang Wei

Abstract readCase ReportsReview
In one paragraph

Review in Diagnostic pathology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Han-Yue XueThe First Clinical Medical College of Shanxi Medical University, 56 Xinjian South Road, Yingze District, Taiyuan, Shanxi, China.
Lin ZhouDepartment of Nephropathy, Bao Ji High-Tech Hospital, Bao Ji, Shaanxi, People's Republic of China.
Qin-Zhao YuanDepartment of Bone and Soft Tissue Oncology, Cancer Hospital of the Chinese Academy of Medical Sciences, Shanxi Hospital, Shanxi Provincial Cancer Hospital, Taiyuan, Shanxi, People's Republic of China.
Yang ZhangDepartment of Hematology, The First Hospital of Shanxi Medical University, 85 Jiefang South Road, Yingze District, Taiyuan, Shanxi, People's Republic of China.
Yi-Qun HaoDepartment of Rheumatology and Immunology, The First Hospital of Shanxi Medical University, Taiyuan, Shanxi, People's Republic of China.
Shao-Wei ChenDepartment of Hematology, The First Hospital of Shanxi Medical University, 85 Jiefang South Road, Yingze District, Taiyuan, Shanxi, People's Republic of China.
Hong-Kun WangDepartment of Pathology, The First Hospital of Shanxi Medical University, Taiyuan, Shanxi, People's Republic of China.
Fang WeiDepartment of Hematology, The First Hospital of Shanxi Medical University, 85 Jiefang South Road, Yingze District, Taiyuan, Shanxi, People's Republic of China. 2649929367@qq.com.

Funding

Natural Science Foundation of Shanxi Province 201801D121223Shanxi Scholarship Council of China 2023-187
6 · The paper itself

Abstract

backgroundPolyneuropathy, organomegaly, endocrinopathy, M-protein, and skin changes (POEMS) syndrome is a rare plasma cell (PC) neoplasm with associated paraneoplastic syndrome. According to the current diagnostic criteria, peripheral polyneuropathy and monoclonal PC proliferative disorder represent two mandatory criteria. CASE PRESENTATION: We report a 54-year-old male with peripheral neuropathy of bilateral lower limbs, sclerotic bone lesions, elevated vascular endothelial growth factor (VEGF) levels, splenomegaly, extravascular volume overload, endocrinopathy, and skin hemangiomas. Of note, serum and urine protein electrophoresis (PEP) and immunofixation electrophoresis (IFE) of this patient indicated undetectable M-protein and the normal ratio of free light chains κ and λ (FLC-R (κ/λ)). No monoclonal PCs were found in bone marrow examinations or biopsy of diseased bones. However, his clinical manifestations matched most of the diagnostic criteria. After excluding other diseases that are easily confused with POEMS syndrome, the diagnosis of variant POEMS syndrome with undetectable M-protein was proposed. The patient obtained clinically significant improvement and elevated VEGF returned to normal after 6 months of treatment with lenalidomide plus dexamethasone.

conclusionsMonoclonal PC dyscrasia (M-protein) while being a mandatory criterion for POEMS syndrome is undetectable in a considerable amount of patients that otherwise demonstrate typical symptoms. Here, we reported a case of variant POEMS syndrome with featured clinical manifestations, elevated VEGF levels, and good response to therapies targeting PCs but no evidence of M-protein. Therefore, negative results in M-protein and monoclonal PCs aren't enough to reject the diagnosis of POEMS syndrome. It is imperative to recognize the variant form of POEMS syndrome.

Indexed as

POEMS SyndromeDexamethasoneHumansLenalidomideMaleMiddle AgedMyeloma ProteinsThalidomideTreatment OutcomeVascular Endothelial Growth Factor ADexamethasoneLenalidomideMyeloma ProteinsThalidomideVascular Endothelial Growth Factor AVEGFA protein, humanDiagnosisM-proteinPlasma cellPOEMS syndrome

Identifiers

PMID38849857
PMCPMC11157949

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.